Drug
Bamlanivimab
Bamlanivimab: highest development phase Phase 3, developed by Eli Lilly. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bamlanivimab NCT04497987 | Phase 3 | COVID-19 |
| Bamlanivimab NCT04634409 | Phase 2 | COVID-19 |
| Bamlanivimab NCT04701658 | Phase 2 | COVID-19 |
Latest
No recent events.
Follow Bamlanivimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.